Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study

Introduction: Ezrin, also known as cytovillin, is a member of the ERM family of protein. Ezrin cross-links actin filament with the plasma membrane. They are involved in the formation of microvilli, cell–cell adhesion, maintenance of cell shape, cell motility, and membrane trafficking. Recent analysi...

Full description

Bibliographic Details
Main Authors: Raghini Mohanraj, Pratibha Ramani, Priya Premkumar, Anuja Natesan, Herald J Sherlin, Gheena Sukumaran
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2017;volume=9;issue=5;spage=205;epage=210;aulast=Mohanraj
_version_ 1818480588628164608
author Raghini Mohanraj
Pratibha Ramani
Priya Premkumar
Anuja Natesan
Herald J Sherlin
Gheena Sukumaran
author_facet Raghini Mohanraj
Pratibha Ramani
Priya Premkumar
Anuja Natesan
Herald J Sherlin
Gheena Sukumaran
author_sort Raghini Mohanraj
collection DOAJ
description Introduction: Ezrin, also known as cytovillin, is a member of the ERM family of protein. Ezrin cross-links actin filament with the plasma membrane. They are involved in the formation of microvilli, cell–cell adhesion, maintenance of cell shape, cell motility, and membrane trafficking. Recent analysis reveals their involvement in signaling pathways. Ezrin is highly expressed in several types of human cancers, and correlation between its immunoreactivity and histopathological data as well as the patient outcome has previously been studied. Objective: The objective of the study was to analyze the immunohistochemical expression pattern of ezrin in oral potentially malignant disorders (OPMDs), namely, oral submucous fibrosis (OSMF) with different grades and clinically leucoplakia (hyperkeratosis with various degree of dysplasia) and its use as a predictive marker for malignant transformation. Subjects and Methods: Sample size n = 43, histopathologically confirmed cases of OPMDs (13 cases of OSMF with different grades and 30 cases of clinically leukoplakia) were retrieved from the Department of Oral and Maxillofacial Pathology. Immunohistochemistry was done using anti-ezrin antibody, and the expression was graded in terms of proportion and intensity. Results: There was a significant expression of ezrin in OPMDs, and its cytoplasmic shift can be used as a predictive marker for malignant transformation. Conclusion: The findings of the current study revealed that the expression of ezrin in OPMDs may be related to the progression of the disease.
first_indexed 2024-12-10T11:25:27Z
format Article
id doaj.art-21aba4b86c1e4fe981ed42eb01f7264e
institution Directory Open Access Journal
issn 0975-7406
language English
last_indexed 2024-12-10T11:25:27Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Pharmacy and Bioallied Sciences
spelling doaj.art-21aba4b86c1e4fe981ed42eb01f7264e2022-12-22T01:50:45ZengWolters Kluwer Medknow PublicationsJournal of Pharmacy and Bioallied Sciences0975-74062017-01-019520521010.4103/jpbs.JPBS_139_17Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive studyRaghini MohanrajPratibha RamaniPriya PremkumarAnuja NatesanHerald J SherlinGheena SukumaranIntroduction: Ezrin, also known as cytovillin, is a member of the ERM family of protein. Ezrin cross-links actin filament with the plasma membrane. They are involved in the formation of microvilli, cell–cell adhesion, maintenance of cell shape, cell motility, and membrane trafficking. Recent analysis reveals their involvement in signaling pathways. Ezrin is highly expressed in several types of human cancers, and correlation between its immunoreactivity and histopathological data as well as the patient outcome has previously been studied. Objective: The objective of the study was to analyze the immunohistochemical expression pattern of ezrin in oral potentially malignant disorders (OPMDs), namely, oral submucous fibrosis (OSMF) with different grades and clinically leucoplakia (hyperkeratosis with various degree of dysplasia) and its use as a predictive marker for malignant transformation. Subjects and Methods: Sample size n = 43, histopathologically confirmed cases of OPMDs (13 cases of OSMF with different grades and 30 cases of clinically leukoplakia) were retrieved from the Department of Oral and Maxillofacial Pathology. Immunohistochemistry was done using anti-ezrin antibody, and the expression was graded in terms of proportion and intensity. Results: There was a significant expression of ezrin in OPMDs, and its cytoplasmic shift can be used as a predictive marker for malignant transformation. Conclusion: The findings of the current study revealed that the expression of ezrin in OPMDs may be related to the progression of the disease.http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2017;volume=9;issue=5;spage=205;epage=210;aulast=MohanrajCytovillinezrinimmunohistochemistryleukoplakiaoral potentially malignant disordersoral submucous fibrosis
spellingShingle Raghini Mohanraj
Pratibha Ramani
Priya Premkumar
Anuja Natesan
Herald J Sherlin
Gheena Sukumaran
Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study
Journal of Pharmacy and Bioallied Sciences
Cytovillin
ezrin
immunohistochemistry
leukoplakia
oral potentially malignant disorders
oral submucous fibrosis
title Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study
title_full Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study
title_fullStr Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study
title_full_unstemmed Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study
title_short Immunohistochemical expression of ezrin in oral potentially malignant disorders-A descriptive study
title_sort immunohistochemical expression of ezrin in oral potentially malignant disorders a descriptive study
topic Cytovillin
ezrin
immunohistochemistry
leukoplakia
oral potentially malignant disorders
oral submucous fibrosis
url http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2017;volume=9;issue=5;spage=205;epage=210;aulast=Mohanraj
work_keys_str_mv AT raghinimohanraj immunohistochemicalexpressionofezrininoralpotentiallymalignantdisordersadescriptivestudy
AT pratibharamani immunohistochemicalexpressionofezrininoralpotentiallymalignantdisordersadescriptivestudy
AT priyapremkumar immunohistochemicalexpressionofezrininoralpotentiallymalignantdisordersadescriptivestudy
AT anujanatesan immunohistochemicalexpressionofezrininoralpotentiallymalignantdisordersadescriptivestudy
AT heraldjsherlin immunohistochemicalexpressionofezrininoralpotentiallymalignantdisordersadescriptivestudy
AT gheenasukumaran immunohistochemicalexpressionofezrininoralpotentiallymalignantdisordersadescriptivestudy